CT UK High Income Trust (LSE:CHI) was trading about 9% below net asset value on the latest quote data, against a 12-month average of 2.41%. No results were published; the most recent items were a NAV statement on 30 October and a shareholding notice on 23 October.

What happened

CT UK High Income Trust, ticker LSE:CHI, is a constituent of the FTSE All-Share index and belongs to the Investment trust sector. It aims to deliver an attractive annual return through dividends or Capital repayments, with scope for capital growth, investing mainly in UK equities across the market-capitalisation range.

The trust's announcement list since mid-October consists almost entirely of daily net asset value statements. The one exception is a Holding(s) in Company notice on 23 October, whose contents we have not read, so we cannot say who was involved or whether a position rose or fell. (LSE:CHI)

The date most relevant to holders is 6 November, when AJ Bell shows a 1.40p Dividend falling due. That payment went ex on 1 October, and the previous dividend, also 1.40p, was paid on 7 August.

Why it matters for investors

The shift in the rating is the notable feature of the current data. A discount of 9.08% is nearly four times the 12-month average of 2.41%, a much larger gap than is usual for this trust on that measure.

The material we retrieved does not explain the change, and we do not want to guess at a specific cause. One possibility, in general terms, is that sellers have outnumbered buyers in a small trust, where market Capitalisation of under £100 million can leave the price more sensitive to individual trades. The shareholding notice may or may not be connected.

A wider discount also changes what a buyer receives. At a listed Yield of 5.1%, the holder receives income on a portfolio bought at below its asset value, although a gap can persist or widen further. The trust's ongoing charge of 1.04% is also a consideration for a fund of this size.

The portfolio at 30 September was weighted towards large UK dividend payers. HSBC led at 8.48% of assets, ahead of Rolls-Royce at 4.85%, Shell at 4.59%, BP at 4.11% and British American Tobacco at 3.73%. GSK, Glencore, AstraZeneca, Standard Life and NatWest made up the rest of the top ten.

On our analysis, banks, oil and pharmaceuticals feature prominently, so the trust's income depends considerably on those sectors. The mandate's reach across company sizes is not evident from the top ten alone, since those names are all large companies.

How the shares have performed

AJ Bell's page showed a quote of 108p to 110p, up 1.50p or 1.40% from the previous close of 107p, with the latest trades dated 2 November and prices delayed by at least 15 minutes.

The 52-week range is 97p to 126p, so the shares remain well below the high. Market Capitalisation was £98.60 million.

The latest actual NAV was 118.08p at 29 October, with an estimate of 117.69p. Returns beyond a single day were not available on the page we retrieved, so we cannot state how the shares have fared over longer periods.

What to watch next

Friday's dividend payment is the next scheduled event. After that, the announcement list will show whether further shareholding notices follow the one on 23 October, and whether the board responds to the wider gap, for example with buybacks.

None of the recent headlines refers to repurchases, a takeover, a Merger or a wind-down. We reviewed those as a list rather than reading each one.

Daily NAV statements will allow investors to judge whether the discount moves back towards its one-year norm. If it does not, shareholders may look for comment from the board in the trust's next report.